Andrew Walz to sell Chevron (NYSE: CVX) shares via Form 144 notice

Rhea-AI Filing Summary

Andrew B. Walz reported proposed sales of common stock under Form 144. The filing lists exercises of options under a registered plan on 03/02/2026 showing 5,000 and 6,600 shares tied to cash exercises. The filing also discloses prior open-market sales by Mr. Walz of 1,463 shares on 02/18/2026 for $268,949.87, 666 shares on 02/12/2026 for $122,144.40, and 22,200 shares on 02/03/2026 for $3,919,050.36.

Insights

Insider Transactions Analyst

Form 144 shows proposed dispositions and recent open-market sales by the reporting person.

Andrew B. Walz filed notice of proposed sales including exercises under a registered plan for 5,000 and 6,600 common shares on 03/02/2026. The methods are listed as cash exercises to the issuer.

Prior transactions disclosed in the excerpt include open-market sales of 22,200, 1,463, and 666 shares with aggregate proceeds shown. Timing and dollar proceeds for each sale are provided in the filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11600	2187517.46	1995385539	03/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Exercise of options under a registered plan	Issuer			5000	03/02/2026	Cash
Common	03/02/2026	Exercise of options under a registered plan	Issuer			6600	03/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREW B WALZ 1400 Smith Street Houston TX 77002	Common	02/18/2026	1463	268949.87
ANDREW B WALZ 1400 Smith Street Houston TX 77002	Common	02/12/2026	666	122144.40
ANDREW B WALZ 1400 Smith Street Houston TX 77002	Common	02/03/2026	22200	3919050.36

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Andrew B. Walz disclose on Form 144 for CVX?

He disclosed proposed dispositions including option exercises for 5,000 and 6,600 shares on 03/02/2026. The filing also lists prior open-market sales of 22,200, 1,463, and 666 shares with stated proceeds.

How many shares did Mr. Walz sell earlier in February 2026?

He sold a total of 24,329 shares in February 2026 across three trades. The filing lists 22,200, 1,463, and 666 share sales with respective proceeds of $3,919,050.36, $268,949.87, and $122,144.40.

Are the 5,000 and 6,600 shares being sold as exercises or open‑market trades?

The filing describes those amounts as exercise of options under a registered plan on 03/02/2026, with the method noted as cash to the issuer. The entries are tied to option exercises rather than brokered open‑market transactions.

What proceeds are shown for Mr. Walz's prior sales?

The excerpt shows proceeds for each prior sale: $3,919,050.36 for 22,200 shares, $268,949.87 for 1,463 shares, and $122,144.40 for 666 shares, as listed in the filing.

Does the filing state how the proposed sales will be executed?

The entries for the 5,000 and 6,600 share amounts are labeled as exercise of options under a registered plan and show cash to the issuer. Other execution details or broker routing are not included in the excerpt.